51.83 USD
▼-1.13-2.13%
盘后 51.88 +0.10%
2026-09-15
市值
$5.01B
市盈率
—
EPS
-4.76
股息率
—
52 周区间
44.12 – 78.48
成交量
1.25M
Beta
1.76
目标价
87.56
52W 低 44.1252W 高 78.48
价格走势
公司简介
CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious human diseases using its Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. The company’s CRISPR/Cas9 is a technology for gene editing which is the process of precisely altering specific sequences of genomic DNA. It has a portfolio of therapeutic programs across a range of disease areas, including hemoglobinopathies, CAR T cell therapies, in vivo, and type 1 diabetes, as well as deve...